Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
02-23 | Clearmind Medicine Says Israel Approves Start of Clinical Trial of CMND-100 for Alcohol Use Disorder | MT |
02-05 | Clearmind Medicine Receives Patent Approval in China | MT |
Sales 2015 | - | Sales 2016 | - | Capitalization | 11.92M 929M |
---|---|---|---|---|---|
Net income 2015 | - 0 | Net income 2016 | - 0 | EV / Sales 2015 * | - |
Net cash position 2015 * | - 0 | Net cash position 2016 * | - 0 | EV / Sales 2016 * | - |
P/E ratio 2015 * |
-
| P/E ratio 2016 * |
-
| Employees | - |
Yield 2015 * |
-
| Yield 2016 * |
-
| Free-Float | 95.71% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 11.92M | |
+43.75% | 1,287B | |
-1.79% | 28.67B | |
-14.47% | 8.42B | |
-23.88% | 2.03B | |
-25.31% | 1.38B | |
+37.30% | 960M | |
-7.54% | 574M | |
+19.40% | 420M | |
-16.37% | 397M |
- Stock Market
- Equities
- CMND Stock